GVS SPA (GVS.MI) Stock Fundamental Analysis
Europe - BIT:GVS - IT0005411209 - Common Stock
4.795 EUR
-0.05 (-1.13%)
GVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. GVS has a medium profitability rating, but doesn't score so well on its financial health evaluation. GVS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year GVS was profitable.
In the past year GVS had a positive cash flow from operations.
Each year in the past 5 years GVS has been profitable.
GVS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GVS has a Return On Assets of 3.59%. This is comparable to the rest of the industry: GVS outperforms 54.24% of its industry peers.
GVS has a better Return On Equity (7.40%) than 62.71% of its industry peers.
GVS has a better Return On Invested Capital (5.89%) than 62.71% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GVS is below the industry average of 8.90%.
The 3 year average ROIC (5.58%) for GVS is below the current ROIC(5.89%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.59% | ||
| ROE | 7.4% | ||
| ROIC | 5.89% |
ROA(3y)2.47%
ROA(5y)7.49%
ROE(3y)6.28%
ROE(5y)14.78%
ROIC(3y)5.58%
ROIC(5y)11.73%
1.3 Margins
Looking at the Profit Margin, with a value of 7.79%, GVS is in the better half of the industry, outperforming 61.02% of the companies in the same industry.
GVS's Profit Margin has declined in the last couple of years.
GVS has a Operating Margin of 13.71%. This is in the better half of the industry: GVS outperforms 69.49% of its industry peers.
GVS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 56.27%, GVS perfoms like the industry average, outperforming 55.93% of the companies in the same industry.
In the last couple of years the Gross Margin of GVS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.71% | ||
| PM (TTM) | 7.79% | ||
| GM | 56.27% |
OM growth 3Y-17.84%
OM growth 5Y-7.16%
PM growth 3Y-26.97%
PM growth 5Y-11.75%
GM growth 3Y-3.53%
GM growth 5Y-1.47%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GVS is destroying value.
GVS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GVS has more shares outstanding
Compared to 1 year ago, GVS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.40 indicates that GVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.40, GVS is in line with its industry, outperforming 52.54% of the companies in the same industry.
The Debt to FCF ratio of GVS is 5.44, which is a neutral value as it means it would take GVS, 5.44 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GVS (5.44) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.58 indicates that GVS is somewhat dependend on debt financing.
GVS has a Debt to Equity ratio of 0.58. This is in the lower half of the industry: GVS underperforms 66.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 5.44 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.83
WACC7.08%
2.3 Liquidity
GVS has a Current Ratio of 1.72. This is a normal value and indicates that GVS is financially healthy and should not expect problems in meeting its short term obligations.
GVS's Current ratio of 1.72 is in line compared to the rest of the industry. GVS outperforms 49.15% of its industry peers.
GVS has a Quick Ratio of 1.25. This is a normal value and indicates that GVS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GVS (1.25) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.25 |
3. Growth
3.1 Past
GVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.25%, which is quite impressive.
Measured over the past 5 years, GVS shows a small growth in Earnings Per Share. The EPS has been growing by 0.08% on average per year.
The Revenue has been growing slightly by 1.69% in the past year.
The Revenue has been growing by 13.51% on average over the past years. This is quite good.
EPS 1Y (TTM)32.25%
EPS 3Y-21.12%
EPS 5Y0.08%
EPS Q2Q%-80%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y8.22%
Revenue growth 5Y13.51%
Sales Q2Q%3.19%
3.2 Future
GVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.71% yearly.
Based on estimates for the next years, GVS will show a small growth in Revenue. The Revenue will grow by 4.99% on average per year.
EPS Next Y8.87%
EPS Next 2Y16.3%
EPS Next 3Y14.71%
EPS Next 5YN/A
Revenue Next Year3.43%
Revenue Next 2Y4.46%
Revenue Next 3Y4.99%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 31.97, GVS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of GVS is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.20. GVS is around the same levels.
With a Price/Forward Earnings ratio of 14.47, GVS is valued correctly.
Based on the Price/Forward Earnings ratio, GVS is valued cheaply inside the industry as 84.75% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.71. GVS is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.97 | ||
| Fwd PE | 14.47 |
4.2 Price Multiples
GVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GVS is cheaper than 83.05% of the companies in the same industry.
89.83% of the companies in the same industry are more expensive than GVS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.18 | ||
| EV/EBITDA | 11.46 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GVS does not grow enough to justify the current Price/Earnings ratio.
GVS has a very decent profitability rating, which may justify a higher PE ratio.
GVS's earnings are expected to grow with 14.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.61
PEG (5Y)378.44
EPS Next 2Y16.3%
EPS Next 3Y14.71%
5. Dividend
5.1 Amount
GVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:GVS (9/17/2025, 11:19:33 AM)
4.795
-0.05 (-1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners20.13%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap907.12M
Analysts75.56
Price Target6.45 (34.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-6.4%
Max Revenue beat(2)1.99%
Revenue beat(4)1
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-6.4%
Max Revenue beat(4)1.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.32%
PT rev (3m)-2.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-14.15%
EPS NY rev (3m)-14.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-2.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.97 | ||
| Fwd PE | 14.47 | ||
| P/S | 2.12 | ||
| P/FCF | 15.18 | ||
| P/OCF | 9.34 | ||
| P/B | 2.01 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.46 |
EPS(TTM)0.15
EY3.13%
EPS(NY)0.33
Fwd EY6.91%
FCF(TTM)0.32
FCFY6.59%
OCF(TTM)0.51
OCFY10.71%
SpS2.27
BVpS2.38
TBVpS-0.12
PEG (NY)3.61
PEG (5Y)378.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.59% | ||
| ROE | 7.4% | ||
| ROCE | 7.74% | ||
| ROIC | 5.89% | ||
| ROICexc | 6.14% | ||
| ROICexgc | 17.51% | ||
| OM | 13.71% | ||
| PM (TTM) | 7.79% | ||
| GM | 56.27% | ||
| FCFM | 13.95% |
ROA(3y)2.47%
ROA(5y)7.49%
ROE(3y)6.28%
ROE(5y)14.78%
ROIC(3y)5.58%
ROIC(5y)11.73%
ROICexc(3y)7.42%
ROICexc(5y)17.74%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.34%
ROCE(5y)15.42%
ROICexcg growth 3Y-16.96%
ROICexcg growth 5Y-11.72%
ROICexc growth 3Y-26.6%
ROICexc growth 5Y-19.5%
OM growth 3Y-17.84%
OM growth 5Y-7.16%
PM growth 3Y-26.97%
PM growth 5Y-11.75%
GM growth 3Y-3.53%
GM growth 5Y-1.47%
F-Score9
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 5.44 | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 84.34% | ||
| Cap/Sales | 8.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.27% | ||
| Profit Quality | 179.13% | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.25 | ||
| Altman-Z | 2.4 |
F-Score9
WACC7.08%
ROIC/WACC0.83
Cap/Depr(3y)69.47%
Cap/Depr(5y)94.36%
Cap/Sales(3y)7.08%
Cap/Sales(5y)7.35%
Profit Quality(3y)312.64%
Profit Quality(5y)218.33%
High Growth Momentum
Growth
EPS 1Y (TTM)32.25%
EPS 3Y-21.12%
EPS 5Y0.08%
EPS Q2Q%-80%
EPS Next Y8.87%
EPS Next 2Y16.3%
EPS Next 3Y14.71%
EPS Next 5YN/A
Revenue 1Y (TTM)1.69%
Revenue growth 3Y8.22%
Revenue growth 5Y13.51%
Sales Q2Q%3.19%
Revenue Next Year3.43%
Revenue Next 2Y4.46%
Revenue Next 3Y4.99%
Revenue Next 5YN/A
EBIT growth 1Y15.17%
EBIT growth 3Y-11.09%
EBIT growth 5Y5.39%
EBIT Next Year54.25%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-18.55%
FCF growth 3Y22.79%
FCF growth 5Y7.4%
OCF growth 1Y-4.37%
OCF growth 3Y20.52%
OCF growth 5Y12.09%